FDA Approved Fibromyalgia Treatment Drug
Fibromyalgia Treatment Drug
FDA approved Fibromyalgia & Fatigue Centers's first drug to treat Fibromyalgia.
Fibromyalgia & Fatigue Centers, Inc., a national network of medical centers that specialize in treating patients with Fibromyalgia and Chronic Fatigue Syndrome, welcomes this announcement as one more step towards increasing recognition and validation by U.S. government health officials and others in the healthcare community of the seriousness of Fibromyalgia.
With the number of Americans suffering from this debilitating condition having risen in recent years to nearly 12 million, Fibromyalgia represents a population of nearly 4%, and can no longer be ignored by the medical community. While the need for continued research and studies still exists, the importance of the FDA announcement represents a change in acceptance as well as thinking.
"It is the experience of treating nearly 9000 sufferers nationwide that Fibromyalgia and Fatigue Centers welcomes the FDA's efforts," states Robert Baurys, founder of Fibromyalgia & Fatigue Centers, Inc. "This announcement is an important step in recognizing this complex condition and is just one of many important components to effectively treat the pain experienced by those suffering with this debilitating condition."
Fibromyalgia & Fatigue Centers specializes in utilizing a combined treatment approach, along with addressing the underlying issues that cause Fibromyalgia. "80% of our patients typically experience improvement in their symptoms by their 4th visit," states Baurys.
As the FDA announcement permeates through the community of Fibromyalgia sufferers, it is essential to understand the medical management required in treating this illness. Fibromyalgia treatment is not accomplished in a single short visit with a physician and a comprehensive integrative approach is essential for successful results.